story of the week
Efficacy and Safety of Dupilumab in the Treatment of Patients With COPD With Blood Eosinophil Evidence of Type 2 Inflammation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
N. Engl. J. Med 2024 Jun 27;390(24)2274-2283, SP Bhatt, KF Rabe, NA Hanania, CF Vogelmeier, M Bafadhel, SA Christenson, A Papi, D Singh, E Laws, N Patel, GD Yancopoulos, B Akinlade, J Maloney, X Lu, D Bauer, A Bansal, RM Abdulai, LB RobinsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.